![Ozone therapy recently hit the headlines as one of the many treatment options being examined to mitigate the effects of COVID-19 [1], but it is also showing great promise in the treatment of neurodegenerative conditions such as Alzheimer’s and Parkinson's.](https://www.longevity.technology/wp-content/uploads/2020/10/Ozone-therapyW-218x150.jpg "Stopping neurodegeneration in its tracks with ozone therapy")
Astellas to acquire iota Biosciences
Following an R&D collaboration that began last year, Japanese pharma Astellas has announced it will...
OneSkin launches topical senetherapeutic skin treatment
Extending skinspan with non-invasive senetherapeutic proprietary peptide.
OneSkin is a Longevity company on a mission to...
Move over, cartography – this is heartography
A new, highly-detailed cellular and molecular map of the human heart could guide personalised treatments.
A...
Neurotech2020: It’s a brave new world
It's an online conference, but not as you know it. Say goodbye to Zoom fatigue...
Why government must unlock biotech’s potential to maximise Longevity
Breanna Deutsch joins us for a guest editorial to advocate for the increased prioritisation of...
